Go Pro
CVE:SYN

Syncordia Technologies and Healthcare Solutions (SYN) Stock Price, News & Analysis

Syncordia Technologies and Healthcare Solutions logo
C$0.04 -0.01 (-22.22%)
As of 04/4/2018

About Syncordia Technologies and Healthcare Solutions Stock (CVE:SYN)

Key Stats

Today's Range
C$0.03
C$0.04
50-Day Range
C$0.04
C$0.04
52-Week Range
C$0.03
C$0.32
Volume
91,000 shs
Average Volume
76,422 shs
Market Capitalization
C$688.84 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SYN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Syncordia Technologies and Healthcare Solutions and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SYN Stock News Headlines

Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel
Microsoft unveils health care AI tools
See More Headlines

SYN Stock Analysis - Frequently Asked Questions

Syncordia Technologies and Healthcare Solutions' stock was trading at C$0.04 on January 1st, 2026. Since then, SYN stock has increased by 0.0% and is now trading at C$0.04.

Shares of SYN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Syncordia Technologies and Healthcare Solutions investors own include NVIDIA (NVDA), SNDL (SNDL), Ambarella (AMBA), iShares Core 30/70 Conservative Allocation ETF (AOK), Baidu (BIDU) and Ceva (CEVA).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Electronic Computer Manufacturing
Sub-Industry
N/A
Current Symbol
CVE:SYN
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
19,681,000
Free Float
N/A
Market Cap
C$688.84 thousand
Optionable
Not Optionable
Beta
N/A
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (CVE:SYN) was last updated on 7/22/2026 by MarketBeat.com Staff.
From Our Partners